Clinical Trials Logo

Clinical Trial Summary

The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.


Clinical Trial Description

the study is following woman retrospectively through their pregnancy from the first trimester troughout delivery .

we will measure the relation between first and/or second trimester bleeding ( threatend abortion ) and pregnancy outcome ( as written below ) - maternal and neonatal . ;


Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02686112
Study type Observational
Source Bnai Zion Medical Center
Contact
Status Completed
Phase N/A
Start date January 2007
Completion date January 2016

See also
  Status Clinical Trial Phase
Completed NCT02420769 - Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion N/A
Withdrawn NCT01501890 - Progesterone for First Trimester Vaginal Bleeding N/A
Completed NCT03930212 - Progesterone Supplementation in Threatened Abortion Phase 4
Completed NCT04788108 - Oral Progesterone for Prevention of Miscarriage in Threatened Abortion Phase 4